Medicare Enrolled

Dr. Pinkas Lebovits, M.D.

Optician · New York, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
200 W 58TH ST, New York, NY 10019
2127577010
Registered in NPPES since 2005
NPI: 1023015245 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lebovits from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lebovits? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lebovits

Dr. Pinkas Lebovits is an optician specialist in New York, NY, with 21 years of NPI registration. Based on federal Medicare data, Dr. Lebovits performed 4,943 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Lebovits received a total of $3,744 from 27 pharmaceutical and/or device companies across 173 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lebovits is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 21 years of NPI registration ▲ Top 16% volume in NY $3,744 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
4,943
Medicare services
Top 16% in NY for optician
Not available
Unique patients (not deduplicated)
$43
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14
This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer.
2,391 $6 $25
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
849 $82 $153
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
370 $46 $118
Skin biopsy, tangential
A procedure to remove a sample of the first identified skin growth for laboratory examination.
309 $83 $181
Destruction of skin growths (warts/lesions), 1-14
This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface.
226 $102 $202
Additional skin growth biopsy
Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session.
122 $48 $88
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
121 $96 $194
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
98 $1 $25
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
94 $51 $101
Destruction of skin growth, 15 or more growths 88 $124 $237
Injection into skin growths, more than 7
A procedure involving the injection of medication into more than seven skin growths.
70 $64 $123
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
58 $116 $220
Destruction of 15 or more precancerous skin growths
This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer.
32 $162 $301
Simple drainage of skin abscess
A minor procedure to drain a localized collection of pus from the skin. The abscess is opened to allow the fluid to escape and promote healing.
29 $110 $221
Injection into skin growths, 1-7
A procedure involving the injection of medication into one to seven skin growths.
27 $51 $99
Acne surgery
A surgical procedure to treat acne. The specific techniques and extent of the surgery are not defined in this general code description.
21 $91 $208
New patient office visit, 15-29 minutes
An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold.
20 $58 $124
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
18 $155 $283
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.4% high complexity
12.7% medium
86.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$3,744
Total received (2018-2024)
Avg $535/year across 7 years
Top 29% in NY for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
173
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$584
2023
$403
2022
$981
2021
$350
2020
$447
2019
$529
2018
$449

Payments by company (2024)

Dermavant Sciences, Inc.
$246
PFIZER INC.
$78
ABBVIE INC.
$70
Arcutis Biotherapeutics, Inc.
$62
Amgen Inc.
$54
Regeneron Healthcare Solutions, Inc.
$33
Incyte Corporation
$23
SUN PHARMACEUTICAL INDUSTRIES INC.
$18
Top 3 companies account for 67.4% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$720
Janssen Biotech, Inc.
$445
AbbVie, Inc.
$435
Lilly USA, LLC
$311
PFIZER INC.
$254
Dermavant Sciences, Inc.
$246
Arcutis Biotherapeutics, Inc.
$208
Novartis Pharmaceuticals Corporation
$163
NOVARTIS PHARMACEUTICALS CORPORATION
$133
Amgen Inc.
$128
AbbVie Inc.
$103
Galderma Laboratories, L.P.
$74
Celgene Corporation
$67
SUN PHARMACEUTICAL INDUSTRIES INC.
$55
Regeneron Healthcare Solutions, Inc.
$54
E.R. Squibb & Sons, L.L.C.
$52
SANOFI-AVENTIS U.S. LLC
$49
Sun Pharmaceutical Industries Inc.
$43
GENZYME CORPORATION
$42
MAYNE PHARMA COMMERCIAL LLC
$28
Nabriva Therapeutics, plc
$25
Incyte Corporation
$23
LEO Pharma Inc.
$21
Mayne Pharma Inc.
$18
EPI Health, LLC
$18
Merck Sharp & Dohme Corporation
$13
Novum Pharma, LLC
$12
Top 3 companies account for 42.8% of all-time payments
Associated products mentioned in payments ›
ADBRY · Alcortin A · CIBINQO · COSENTYX · DORYX · DUPIXENT · EUCRISA · HUMIRA · Humira · ILUMYA · Ilumya · OPZELURA · ORACEA · Otezla · REMICADE · RINVOQ · SIVEXTRO · SKYRIZI · SOOLANTRA · Sitavig · Sivextro · Skyrizi · TALTZ · TREMFYA · Tremfya · VTAMA · Winlevi · Zoryve
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an optician specialist in New York?
Compare opticians in the New York area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians in nearby ZIP areas
15,822
County median income
$104,553
Nearest hospital to ZIP centroid (approximate)
MOUNT SINAI WEST
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Lebovits is a clinical cardiology specialist, with above-average Medicare volume (top 16% in NY), with 21 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Lebovits experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Lebovits performed 2,391 destruction of precancerous skin growths, 2-14 services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Lebovits receive payments from pharmaceutical companies?
Yes. Dr. Lebovits received a total of $3,744 from 27 companies across 173 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lebovits's costs compare to other opticians in New York?
Dr. Lebovits's average Medicare payment per service is $43. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lebovits) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →